Glucotrack (GCTK) Capital Expenditures Growth (3y) (2013 - 2025)
Glucotrack (GCTK) Capital Expenditures Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -18.96% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -11.61% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 5.31% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -31.75% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 5.49% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -21.70% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -6.01% |
| 10 | Glucotrack | 4.26 | -7.38 Mn | - | 105.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 105.41% |
| Dec 31, 2022 | -105.88% |
| Dec 31, 2021 | 28.94% |
| Sep 30, 2020 | 28.48% |
| Mar 31, 2020 | 116.56% |
| Sep 30, 2019 | -24.07% |
| Jun 30, 2019 | -45.99% |
| Mar 31, 2019 | -35.67% |
| Sep 30, 2018 | -72.41% |
| Jun 30, 2018 | -47.52% |
| Mar 31, 2018 | -57.47% |
| Sep 30, 2017 | 60.04% |
| Jun 30, 2017 | -55.81% |
| Mar 31, 2017 | -44.95% |
| Sep 30, 2016 | 17.46% |
| Jun 30, 2016 | -12.22% |
| Mar 31, 2016 | 212.36% |
| Sep 30, 2015 | 180.03% |
| Jun 30, 2015 | 54.37% |
| Mar 31, 2015 | 93.49% |